Hydroxyproline

Identification

Generic Name
Hydroxyproline
DrugBank Accession Number
DB08847
Background

Hydroxyproline is a neutral heterocyclic protein amino acid. It is found in collagen and as such it is common in many gelatin products. Hydroxyproline is mostly used as a diagnostic marker of bone turnover and liver fibrosis. Therapeutically, hydroxyproline is being studied as an an experimental medicine but is approved in France as a combination topical gel product called Cicactive for small, superficial wounds.

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 131.1299
Monoisotopic: 131.058243159
Chemical Formula
C5H9NO3
Synonyms
  • trans-4-Hydroxy-L-proline
  • trans-L-Hydroxyproline

Pharmacology

Indication

Used in France as a combination product for the treatment of small, superficial wounds.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Hydroxyproline as well as proline and glycine are the major components of collagen. Collagen is on one of the main building blocks of connective tissue such as skin, bone, and cartilage. Thus when these tissues are damaged, hydroxyproline is necessary for repair of the damaged area.

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Isa Knox Wrinkle Decline Double Effect Rf3 WrinkleCream0.525 mL/100mLTopicalLg Household & Health Care Ltd.2010-05-202011-03-01US flag
Isa Knox Wrinkle Decline Double Effect Rf3 Wrinkle Eye FillerCream0.525 mL/100mLTopicalLg Household & Health Care Ltd.2010-05-142011-03-01US flag
O Hui Wrinkle Science Deep Wrinkle TreatmentCream0.5 mL/100mLTopicalLg Household & Health Care Ltd.2010-04-302011-06-01US flag
O Hui Wrinkle Science Wrinkle RepairCream0.5 1/100mLTopicalLg Household & Health Care Ltd.2010-04-16Not applicableUS flag
Ohui Skin Science Age Recovery Cell LabCream0.5 mL/100mLTopicalLg Household & Health Care Ltd.2011-01-202012-04-01US flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Ageless Foundation 23Hydroxyproline (0.53 mL/100mL) + Diacetyl benzoyl lathyrol (0.1 mL/100mL) + Dimethicone (0.34 mL/100mL) + Distearyldimonium chloride (0.3 mL/100mL) + Octinoxate (1.5 mL/100mL) + Titanium dioxide (8.24 mL/100mL)LiquidTopicalLg Household & Health Care Ltd.2010-10-222011-10-22US flag
Cathycat Chewy CREAM FOUNDATION SPF23 PA WHITENING ANTI WRINKLE 21Hydroxyproline (0.5 g/100g) + Arbutin (2 g/100g) + Octinoxate (1.5 g/100g) + Titanium dioxide (8.2062 g/100g)LiquidTopicalLg Household & Health Care Ltd.2011-04-152012-04-15US flag
Cathycat Chewy CREAM FOUNDATION SPF23 PA WHITENING ANTI WRINKLE 23Hydroxyproline (0.5 g/100g) + Arbutin (2 g/100g) + Octinoxate (1.5 g/100g) + Titanium dioxide (8.2062 g/100g)LiquidTopicalLg Household & Health Care Ltd.2011-04-152012-04-15US flag
Gongjinhyang Mi Luxury BaseHydroxyproline (0.057 mL/100mL) + Honey (0.01 mL/100mL) + Titanium dioxide (0.057 mL/100mL)CreamTopicalLg Household & Health Care Ltd.2010-04-092011-04-09US flag
Gongjinhyang Mi Luxury Foundation 1Hydroxyproline (0.53 mL/100mL) + Octinoxate (1 mL/100mL)CreamTopicalLg Household & Health Care Ltd.2010-03-302011-03-30US flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Isa Knox Tervina Repair Foundation BbHydroxyproline (0.5 mL/100mL) + Atractylodes lancea root oil (0.05 mL/100mL) + Octinoxate (3 mL/100mL) + Titanium dioxide (1 mL/100mL)LiquidTopicalLg Household & Health Care Ltd.2011-07-012012-04-01US flag
Isa Knox Wrinkle Decline Double Effect Rf3 WrinkleHydroxyproline (0.525 mL/100mL)CreamTopicalLg Household & Health Care Ltd.2010-05-202011-03-01US flag
Isa Knox Wrinkle Decline Double Effect Rf3 Wrinkle Eye FillerHydroxyproline (0.525 mL/100mL)CreamTopicalLg Household & Health Care Ltd.2010-05-142011-03-01US flag
O Hui Wrinkle Science Deep Wrinkle TreatmentHydroxyproline (0.5 mL/100mL)CreamTopicalLg Household & Health Care Ltd.2010-04-302011-06-01US flag
O Hui Wrinkle Science Wrinkle RepairHydroxyproline (0.5 1/100mL)CreamTopicalLg Household & Health Care Ltd.2010-04-16Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as proline and derivatives. These are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Proline and derivatives
Alternative Parents
L-alpha-amino acids / Pyrrolidine carboxylic acids / Secondary alcohols / Amino acids / 1,2-aminoalcohols / Monocarboxylic acids and derivatives / Dialkylamines / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds
show 3 more
Substituents
1,2-aminoalcohol / Alcohol / Aliphatic heteromonocyclic compound / Alpha-amino acid / Amine / Amino acid / Azacycle / Carbonyl group / Carboxylic acid / Hydrocarbon derivative
show 16 more
Molecular Framework
Aliphatic heteromonocyclic compounds
External Descriptors
4-hydroxyproline (CHEBI:18095) / Other amino acids (C01157)
Affected organisms
  • Humans and other mammals

Chemical Identifiers

UNII
RMB44WO89X
CAS number
51-35-4
InChI Key
PMMYEEVYMWASQN-DMTCNVIQSA-N
InChI
InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1
IUPAC Name
(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid
SMILES
O[C@H]1CN[C@@H](C1)C(O)=O

References

Synthesis Reference

Adams, Elijah; Goldstone, Alfred. Hydroxyproline metabolism. II. Enzymic preparation and properties of D1-pyrroline-3-hydroxy-5-carboxylic acid. Journal of Biological Chemistry (1960), 235 3492-8.

General References
Not Available
Human Metabolome Database
HMDB0000725
KEGG Compound
C01157
PubChem Compound
5810
PubChem Substance
175427120
ChemSpider
5605
BindingDB
50357233
RxNav
1311548
ChEBI
18095
ChEMBL
CHEMBL352418
ZINC
ZINC000000901791
PDBe Ligand
HYP
Wikipedia
Hydroxyproline
PDB Entries
1ag7 / 1as5 / 1av3 / 1bdk / 1bkv / 1cag / 1cgd / 1d7t / 1dfy / 1dfz
show 338 more
MSDS
Download (72.1 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2CompletedTreatmentHyperoxaluria1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CreamTopical
CreamTopical0.5 mL/100mL
CreamTopical0.5 1/100mL
EmulsionTopical0.5 mL/100mL
CreamTopical0.51 1/100mL
LiquidTopical
CreamTopical0.525 mL/100mL
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)274°CFrom The Merck Index monographs.
boiling point (°C)DecomposesFrom MSDS.
water solubilitySoluble in water at 0, 25, 50, and 60 °CFrom The Merck Index monographs.
pKapK1′ 1.82 and pK2′ 9.65From The Merck Index monographs.
Predicted Properties
PropertyValueSource
Water Solubility492.0 mg/mLALOGPS
logP-3.3ALOGPS
logP-3.7Chemaxon
logS0.57ALOGPS
pKa (Strongest Acidic)1.64Chemaxon
pKa (Strongest Basic)10.62Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area69.56 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity29.38 m3·mol-1Chemaxon
Polarizability12.29 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9652
Blood Brain Barrier+0.6522
Caco-2 permeable-0.7144
P-glycoprotein substrateNon-substrate0.546
P-glycoprotein inhibitor INon-inhibitor0.9789
P-glycoprotein inhibitor IINon-inhibitor0.987
Renal organic cation transporterNon-inhibitor0.856
CYP450 2C9 substrateNon-substrate0.8242
CYP450 2D6 substrateNon-substrate0.7501
CYP450 3A4 substrateNon-substrate0.6878
CYP450 1A2 substrateNon-inhibitor0.9332
CYP450 2C9 inhibitorNon-inhibitor0.9619
CYP450 2D6 inhibitorNon-inhibitor0.9367
CYP450 2C19 inhibitorNon-inhibitor0.9623
CYP450 3A4 inhibitorNon-inhibitor1.0
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9913
Ames testNon AMES toxic0.9149
CarcinogenicityNon-carcinogens0.964
BiodegradationReady biodegradable0.9178
Rat acute toxicity2.1441 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9682
hERG inhibition (predictor II)Non-inhibitor0.9178
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-000x-0950000000-5b1c397e26b28e872d20
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-000x-0950000000-c46b5bba0f41001e3c18
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (3 TMS)GC-MSsplash10-00di-9530000000-00db00b15ab5341d7d64
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-0a4i-1900000000-c0a869abe2f1e9f8c08e
GC-MS Spectrum - GC-MS (3 TMS)GC-MSsplash10-001l-1960000000-abcd0377696d2b52d815
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0a6r-9100000000-af92b4a861832ca4ec13
GC-MS Spectrum - EI-BGC-MSsplash10-001i-0590000000-75e03328fb2d44469057
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-000x-0950000000-c46b5bba0f41001e3c18
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00di-9530000000-00db00b15ab5341d7d64
GC-MS Spectrum - GC-MSGC-MSsplash10-0a4i-1900000000-c0a869abe2f1e9f8c08e
GC-MS Spectrum - GC-MSGC-MSsplash10-001l-1960000000-abcd0377696d2b52d815
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-000x-0940000000-97328204c6b60a244616
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-000x-0940000000-468aeb79950a9e6dadc6
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a4i-0900000000-40c0bfa9451caacaf422
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-0019-9700000000-ea3ed008938a57d1263c
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-014r-9000000000-0b76109525f362b600a0
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-014l-9000000000-477e41e40831316e68ac
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , PositiveLC-MS/MSsplash10-0019-9300000000-7228a10f32d447b58ee0
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , NegativeLC-MS/MSsplash10-001i-0900000000-11800ca52c6e911f8313
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-001i-0900000000-11800ca52c6e911f8313
MS/MS Spectrum - , negativeLC-MS/MSsplash10-001i-1900000000-b6bba00a324b6eab209f
MS/MS Spectrum - , negativeLC-MS/MSsplash10-001i-1900000000-ba9df49a4d967cf8851d
LC-MS/MS Spectrum - LC-ESI-IT , positiveLC-MS/MSsplash10-000i-9000000000-6d125b0bb59101e9ce53
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0019-9300000000-7228a10f32d447b58ee0
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0019-9600000000-5bcced64c9dfeb96876f
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0019-9600000000-b575fa8df5e2d8bb3a99
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-015i-9300000000-4300a00cd11010f340cb
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-0900000000-0520c3c53d1b640da293
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00kr-9000000000-48ea38cd54f495e2780d
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-067i-9200000000-86e81b2ce08e4149cb93
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-7e1f7bb3ab2ea8ccb074
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-052f-9000000000-ebe593268b467f74e97f
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,1H] 2D NMR Spectrum2D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-123.0785
predicted
DarkChem Lite v0.1.0
[M-H]-123.0768
predicted
DarkChem Lite v0.1.0
[M-H]-123.1028
predicted
DarkChem Lite v0.1.0
[M-H]-121.71372
predicted
DeepCCS 1.0 (2019)
[M+H]+124.2009
predicted
DarkChem Lite v0.1.0
[M+H]+126.8448467
predicted
DarkChem Standard v0.1.0
[M+H]+123.4132
predicted
DarkChem Lite v0.1.0
[M+H]+125.39543
predicted
DeepCCS 1.0 (2019)
[M+Na]+123.6804
predicted
DarkChem Lite v0.1.0
[M+Na]+122.2965
predicted
DarkChem Lite v0.1.0
[M+Na]+123.2415
predicted
DarkChem Lite v0.1.0
[M+Na]+134.5223
predicted
DeepCCS 1.0 (2019)

Transporters

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
L-proline transmembrane transporter activity
Specific Function
Neutral amino acid/proton symporter. Has a pH-dependent electrogenic transport activity for small amino acids such as glycine, alanine and proline. Besides small apolar L-amino acids, it also recog...
Gene Name
SLC36A1
Uniprot ID
Q7Z2H8
Uniprot Name
Proton-coupled amino acid transporter 1
Molecular Weight
53075.045 Da
References
  1. Metzner L, Kalbitz J, Brandsch M: Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1. J Pharmacol Exp Ther. 2004 Apr;309(1):28-35. Epub 2004 Jan 12. [Article]

Drug created at March 02, 2013 01:29 / Updated at June 12, 2020 16:52